Reference curves for CD 4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-na € ı ve patients

V Bouteloup, C Sabin, A Mocroft, L Gras, N Pantazis, V Le Moing, A d’Arminio Monforte, M Mary-Krause, B Roca, JM Miro, M Battegay, N Brockmeyer, J Berenguer, P Morlat, N Obel, S De Wit, G F€atkenheuer, R Zangerle, J Ghosn, S P erez-Hoyos, M Campbell, M Prins, G Chêne, L Meyer, M Dorrucci, C Torti and R Thi ebaut The Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord* CIC 1401, CHU de Bordeaux, Bordeaux, France, INSERM U1219 – Centre Inserm Bordeaux Population Health, Universit e de Bordeaux, Bordeaux, France, ISPED, Centre INSERM U1219-Bordeaux Population Health, Universit e de Bordeaux, Bordeaux, France, Research Department of Infection & Population Health, UCL, London, UK, Stichting HIV Monitoring, Amsterdam, The Netherlands, Department of Hygiene, Epidemiology & Medical Statistics, Athens University Medical School, Athens, Greece, Montpellier University, Montpellier, France, Infectious Diseases Unit, Department of Health Sciences, San Paolo University Hospital, Milan, Italy, INSERM, Institut Pierre Louis d’ epid emiologie et de Sant e Publique (IPLESP UMRS 1136), UPMC Univ Paris 06, Sorbonne Universit es, F-75013, Paris, France, Hospital General of Castellon, Castell on, Spain, Infectious Diseases Service. Hospital Clinic – IDIBAPS, University of Barcelona, Barcelona, Spain, Division of Infectious Diseases and Hospital Epidemiology, Department of Clinical Research, University Hospital of Basel, Basel, Switzerland, Department of Dermatology, Venerology – Center for Sexual Health and Medicine, Ruhr-Universit€at Bochum, Bochum, Germany, Instituto de Investigaci on Sanitaria Gregorio Mara~ n on (IiSGM), Hospital General Universitario Gregorio Mara~ n on, Madrid, Spain, Service de M edecine Interne et Maladies Infectieuses, Hôpital Saint-Andr e, Bordeaux, France, Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark, Department of Infectious Diseases, St Pierre University Hospital, Universit e Libre de Bruxelles, Brussels, Belgium, Department of Internal Medicine, University of Cologne and German Centre for Infection Research (DZIF), Cologne, Germany, Medical University Innsbruck, Innsbruck, Austria, APHP, Unit e Fonctionnelle de Th erapeutique en Immuno-Infectiologie, Centre Hospitalier Universitaire Hôtel Dieu, Paris, France, Facult e de M edecine Site Necker, Sorbonne Paris Cit e, Universit e Paris Descartes, EA 7327, Paris, France, Vall d’Hebr on Institut de Recerca (VHIR), Barcelona, Spain, Universitat Aut onoma de Barcelona, Barcelona, Spain, CHIP, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Division of Infectious Diseases, Department of Internal Medicine, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands, Department of Infectious Diseases, Public Health Service, Amsterdam, The Netherlands, CHU de Bordeaux, Pole de Sante Publique, Service d’Information Medicale, F-33000, Bordeaux, France, INSERM, U1018, Epidemiology of HIV, Reproduction, Paediatrics, CESP; University Paris-Sud, Paris, France, Department of Public Health and Epidemiology, Bicêtre Hospital, AP-HP, Le Kremlin Bicêtre, Paris, France, Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanit a, Rome, Italy and Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, University “Magna Graecia”, Catanzaro, Italy